Form 4 for ANIX Anixa Biosciences Inc
Accepted 2022-01-11 00:00:00 ET · period of report 2022-01-10 · accession 0001493152-22-000899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-11 | 2022-01-10 | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.08 | +6,000 | 971.1K | +0.6% | +$18.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-10 | P | A | 6,000 | $3.08 | 971,070 | D | — | — |